Literature DB >> 18287608

Scientific and legal viability of follow-on protein drugs.

David M Dudzinski1, Aaron S Kesselheim.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18287608     DOI： 10.1056/NEJMhle0706973

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Biosimilar growth hormone.

Authors:  Paul Saenger
Journal:  Indian J Pediatr       Date:  2011-11-23       Impact factor: 1.967

2.  Growth hormone and health policy.

Authors:  Leona Cuttler; J B Silvers
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

3.  Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA.

Authors:  Janice M Reichert; Nitya Jacob; Ashraf Amanullah
Journal:  MAbs       Date:  2009-05-20       Impact factor: 5.857

4.  European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.

Authors:  Janice M Reichert; Alain Beck; Harish Iyer
Journal:  MAbs       Date:  2009-09-25       Impact factor: 5.857

Review 5.  US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins.

Authors:  Marc Cohen; Walter P Jeske; Jose C Nicolau; Gilles Montalescot; Jawed Fareed
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

Review 6.  Neutrophil biology and the next generation of myeloid growth factors.

Authors:  David C Dale
Journal:  J Natl Compr Canc Netw       Date:  2009-01       Impact factor: 11.908

7.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

8.  Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data.

Authors:  Tomasz Romer; Markus Zabransky; Mieczyslaw Walczak; Mieczyslaw Szalecki; Sigrid Balser
Journal:  Biol Ther       Date:  2011-12-16

9.  Current status of biosimilar growth hormone.

Authors:  Paul Saenger
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.